Yahoo Web Search

Search results

  1. Jan 19, 2022 · A vaccine can help prevent dengue, which is caused by four distinct, but closely related dengue viruses, DENV-1, DENV-2, DENV-3, and DENV-4. Only one dengue vaccine is currently available for use: A tetravalent, live-attenuated dengue vaccine (Dengvaxia®)

  2. Feb 2, 2024 · Dengue. Sesai/ Flickr cc. Results of a phase 3 trial in the New England Journal of Medicine ( NEJM) show 80% protection for the single-dose tetravalent (four-strain) Butantan-Dengue Vaccine (Butantan D-V) among participants with no evidence of previous dengue exposure and 89% protection in those with a history of exposure.

  3. The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1,...

  4. Apr 20, 2018 · A safe, effective and affordable dengue vaccine against the four strains would represent a major advance for the control of the disease and could be an important tool for reaching the WHO goal of reducing dengue morbidity by at least 25% and mortality by at least 50% by 2020.

  5. Dengue vaccine can help protect against dengue in people who have had dengue in the past. Dengue is caused by one of four viruses spread through the bite of an infected mosquito. A person can get infected by any of the four dengue viruses. Infection with one dengue virus does not protect against infection with the other three viruses.

  6. Aug 8, 2023 · DENGVAXIA is approved for use in individuals 6 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas. Product Information. Package Insert -...

  7. Feb 4, 2013 · CDC. Just one dose of a low-cost vaccine proved safe and stimulated a strong immune response against the dengue virus in most participants in an early-stage clinical trial. With further development, the vaccine may help ease the burden of dengue fever in developing countries.

  1. People also search for